Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16169723rdf:typepubmed:Citationlld:pubmed
pubmed-article:16169723lifeskim:mentionsumls-concept:C0031397lld:lifeskim
pubmed-article:16169723lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:16169723lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:16169723pubmed:issue23lld:pubmed
pubmed-article:16169723pubmed:dateCreated2005-10-19lld:pubmed
pubmed-article:16169723pubmed:abstractTextA series of 3-trifluoromethyl-1,2,3,4-tetrahydroisoquinolines was synthesized and evaluated for their phenylethanolamine N-methyltransferase (PNMT) inhibitory potency and affinity for the alpha(2)-adrenoceptor. Although their PNMT inhibitory potency decreased compared with corresponding 3-methyl-, 3-hydroxymethyl- or 3-unsubstituted-THIQs, some of them showed good selectivity due to their extremely low alpha(2)-adrenoceptor affinity.lld:pubmed
pubmed-article:16169723pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:languageenglld:pubmed
pubmed-article:16169723pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:citationSubsetIMlld:pubmed
pubmed-article:16169723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16169723pubmed:statusMEDLINElld:pubmed
pubmed-article:16169723pubmed:monthDeclld:pubmed
pubmed-article:16169723pubmed:issn0960-894Xlld:pubmed
pubmed-article:16169723pubmed:authorpubmed-author:HaasD JDJlld:pubmed
pubmed-article:16169723pubmed:authorpubmed-author:GrunewaldGary...lld:pubmed
pubmed-article:16169723pubmed:authorpubmed-author:CriscioneKevi...lld:pubmed
pubmed-article:16169723pubmed:authorpubmed-author:OkoroCosmas...lld:pubmed
pubmed-article:16169723pubmed:issnTypePrintlld:pubmed
pubmed-article:16169723pubmed:day1lld:pubmed
pubmed-article:16169723pubmed:volume15lld:pubmed
pubmed-article:16169723pubmed:ownerNLMlld:pubmed
pubmed-article:16169723pubmed:authorsCompleteYlld:pubmed
pubmed-article:16169723pubmed:pagination5319-23lld:pubmed
pubmed-article:16169723pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:meshHeadingpubmed-meshheading:16169723...lld:pubmed
pubmed-article:16169723pubmed:year2005lld:pubmed
pubmed-article:16169723pubmed:articleTitleInhibitors of phenylethanolamine N-methyltransferase devoid of alpha2-adrenoceptor affinity.lld:pubmed
pubmed-article:16169723pubmed:affiliationDepartment of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence, KS 66045, USA. ggrunewald@ku.edulld:pubmed
pubmed-article:16169723pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16169723pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:16169723pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:16169723pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16169723lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16169723lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16169723lld:pubmed